Call Us08045477330
XBIRA TABLETS 250MG

XBIRA TABLETS 250MG

20000 INR/Box

Product Details:

  • Indication Prostate Cancer, Castration-Resistant
  • Dosage Form Tablet
  • Salt Composition Abiraterone Acetate 250 mg
  • Enzyme Types CYP17 Inhibitor
  • Feature Targeted hormonal therapy for advanced prostate cancer
  • Ingredients Abiraterone Acetate, Excipients
  • Application Oral, Prescription
  • Click to View more
X

XBIRA TABLETS 250MG Price And Quantity

  • 20000 INR/Box
  • 1 Box

XBIRA TABLETS 250MG Product Specifications

  • Abiraterone Acetate, Excipients
  • Targeted hormonal therapy for advanced prostate cancer
  • CYP17 Inhibitor
  • Irreversible CYP17 enzyme inhibition
  • Odorless
  • Store below 30C, protect from moisture
  • White to off-white; film-coated tablet
  • 24 months
  • Abiraterone Acetate 250 mg
  • Oral, Prescription
  • Tablet
  • Prostate Cancer, Castration-Resistant

XBIRA TABLETS 250MG Trade Information

  • MUMBAI
  • Cash on Delivery (COD), Cash Against Delivery (CAD), Cash in Advance (CID)
  • 1000 Box Per Day
  • 1 Week
  • 120 Tablets
  • Australia, Western Europe, Middle East, Africa, Asia
  • All India
  • GMP

Product Description

XbiraTablet 250mg is suited for the treatment of cancer of prostate gland. The provided tablets are used to treat other conditions as well. These medicines are the essential parts of combination chemotherapy. Xbira Tablet 250mg belongs to a special category of medications known asantineoplastics. This is functional as an effective anti-cancer medication included with Abiraterone Acetate. Basically, this is a hormonal treatment and not a chemotherapy medicine. Provided medicine is functional as an anti-cancer drug of safe intake and high effectiveness. 



Targeted Therapy for Advanced Prostate Cancer

XBIRA Tablets offer a specialized approach to managing castration-resistant prostate cancer by irreversibly inhibiting the CYP17 enzyme. This action disrupts hormonal pathways that fuel cancer growth, helping physicians tailor precise treatment regimens for patients who require advanced interventions. The formula is designed for maximum efficacy and safety in eligible male patients.


Safe and Effective Administration

XBIRA is provided in a convenient bottle of 120 tablets, each containing 250 mg of Abiraterone Acetate. The film-coated tablets are administered orally, ensuring ease of use and consistent dosing. Patients should follow physician instructions closely to avoid potential adverse effects and achieve optimal therapeutic outcomes. Storage below 30C prolongs shelf life and maintains product integrity.

FAQs of XBIRA TABLETS 250MG:


Q: How should XBIRA Tablets 250 mg be used?

A: XBIRA tablets should be taken orally exactly as directed by your physician. Consistent timing and adherence to prescribed doses are crucial for effective treatment. Do not alter dosage or discontinue administration without consulting your healthcare provider.

Q: What is the benefit of using XBIRA for castration-resistant prostate cancer?

A: XBIRA provides targeted hormonal therapy by inhibiting the CYP17 enzyme, helping restrict the progression of advanced, castration-resistant prostate cancer. This mechanism allows for improved management of the disease when standard therapies are insufficient.

Q: When is XBIRA contraindicated?

A: XBIRA should not be used in women, children, or patients with known hypersensitivity to Abiraterone Acetate or other tablet components. Always inform your physician of any allergies before starting treatment.

Q: Where should XBIRA Tablets be stored?

A: Store XBIRA tablets below 30C, protected from moisture and direct sunlight. Proper storage conditions help ensure the medications effectiveness for up to its 24-month shelf life.

Q: Is XBIRA safe for self-administration?

A: XBIRA must only be used under strict medical supervision. Self-administration without guidance is not recommended due to potential side effects and the need for regular monitoring during treatment.

Q: What process does XBIRA use to manage prostate cancer?

A: XBIRA works as an irreversible CYP17 inhibitor, blocking enzyme activity involved in androgen production. This process helps reduce cancer-fueling hormones and slows disease progression in castration-resistant cases.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Tablets' category